apolipoprotein A-IV (apolipoprotein AIV)

08/16/1996 - "Protection against atherogenesis in mice mediated by human apolipoprotein A-IV."
08/01/2006 - "The aim of the present study was to evaluate the association of apolipoprotein A-IV (APOA4) polymorphisms with coronary artery calcification (CAC) progression, a marker of subclinical atherosclerosis. "
01/01/1990 - "The baboon has been shown to be a suitable animal model for the study of atherosclerosis, and the existence of a common, multi-allele apolipoprotein A-IV polymorphism in the baboon may be useful in elucidating the role of apolipoprotein A-IV in lipid metabolism."
01/01/2023 - "Apo A-IV glycosylation is closely related to the occurrence and development of diabetic peripheral atherosclerosis. "
11/01/2018 - "Apolipoprotein A-IV: A potential therapeutic target for atherosclerosis."

12/30/2004 - "Apolipoprotein A-IV, food intake, and obesity."
08/01/2004 - "This raises the possibility that dysregulation of hypothalamic apo A-IV could contribute to diet-induced obesity."
08/01/2004 - "Obesity induced by a high-fat diet downregulates apolipoprotein A-IV gene expression in rat hypothalamus."
06/01/2004 - "Whereas it is tempting to speculate that apo A-IV may play a role in diet-induced obesity, we believe the confirmation of such a proposal awaits further experimental evidence."
04/01/2003 - "Further evidence for the association between obesity-related traits and the apolipoprotein A-IV gene."

11/01/2000 - "The present study was designed to evaluate whether the apo A-IV 360His polymorphism could explain, at least in part, the interindividual variability observed during postprandial lipemia. "
01/01/1988 - "[Serum apo A-IV concentration in patients with hyperlipidemia]."
03/01/1995 - "By contrast, genetically induced hypercholesterolemia (Watanabe heritable hyperlipidemia, WHHL mutation) caused a significantly reduced level of apo A-IV (3.8 +/- 1.14 mg/dl, n = 7). "
02/01/1995 - "[Apolipoprotein A-IV and transportation of cholesterol from smooth muscle cells in experimental hyperlipidemia]."
11/01/2000 - "Data of postprandial lipemia revealed that subjects with the apo A-IV 360His allele had significantly greater postprandial levels in small triacylglycerol rich lipoproteins (TRL)-C (P<0.02), small TRL-TG (P<0.01) and large TRL-TG (P<0.05) than apo A-IV 360Gln/Gln subjects. "

12/30/2004 - "Evidence also suggests apo A-IV's involvement in the long-term regulation of food intake and body weight. "
07/01/2004 - "These results indicate that the diurnal expression of hypothalamic apo A-IV is regulated by factors other than the circulating CORT, for example, the reduced food intake and body weight in adrenalectomized animals. "
06/01/2004 - "Additionally, information regarding the general involvement of apo A-IV in the regulation of food intake and body weight is stated. "
01/01/2003 - "Other evidence suggests that apo-A IV may also be involved in the long-term regulation of food intake and body weight. "
01/01/2001 - "Other evidence suggests that apo A-IV may also be involved in the long-term regulation of food intake and body weight. "

08/01/1996 - "The clearance of apo A-IV by the liver may be delayed or apo A-IV synthesis may be rather markedly enhanced during fat absorption in liver cirrhosis."
10/24/2017 - "Of note, apolipoprotein A4 in serum samples obtained from patients in the early stage of liver fibrosis were significantly increased compared to the healthy controls (p<0.001) while the area under curve was 0.966. "
10/24/2017 - "In this regard, overexpression of apolipoprotein A4 in early stage of liver fibrosis might magnify and imply the progression of hepatic fibrosis. "
10/24/2017 - "These findings suggest that apolipoprotein A4 upregulation may correlate with hepatic fibrosis staging and that apolipoprotein A4 together with current biomarker can increase the sensitivity and specificity for the early detection of liver fibrosis in a high-throughput manner."
10/24/2017 - "Proteome-based identification of apolipoprotein A-IV as an early diagnostic biomarker in liver fibrosis."